Publications by authors named "Stephan Hutter"

Claim this Profile
S
Solving Riddles Through Sequencing (SIRIUS): unlocking hematologic diagnoses by whole genome and transcriptome sequencing.
Marietta Truger, Manja Meggendorfer, Wencke Walter, Stephan Hutter, Winfried Alsdorf

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutations in CCUS, MDS and AML: a cross-entity study.
Sandra Huber, Sarah Ochmann, Stephan Hutter, Veronika Ecker, Manja Meggendorfer

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining telomere content and genomics of myeloid neoplasia by whole-genome sequencing.
Luca Guarnera, Adam Wahida, Carmelo Gurnari, Stephan Hutter, Sabine A Stainczyk

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two ways to complex karyotype in MDS-the role of del(5q) and TP53.
Sandra Huber, Stephan Hutter, Constance Baer, Manja Meggendorfer, Gregor Hoermann

Blood Cancer J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid neoplasms with MYC-positive double minutes: towards recognition as a distinct entity.
Isolde Summerer, Wencke Walter, Manja Meggendorfer, Torsten Haferlach, Frank Dicker, Stephan Hutter

Blood Cancer J· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of blast counts for genetic subclassification in MDS.
Sandra Huber, Torsten Haferlach, Stephan Hutter, Gregor Hoermann, Wolfgang Kern

Leukemia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase.
Wencke Walter, Niroshan Nadarajah, Stephan Hutter, Heiko Müller, Claudia Haferlach

Leukemia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high proportion of germline variants in pediatric chronic myeloid leukemia.
Manuela Krumbholz, Anna Dolnik, Eric Sträng, Tabita Ghete, Sabrina Skambraks, Stephan Hutter

Mol Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic landscape of CCUS compared to MDS and its implications on risk prediction.
Sandra Huber, Constance Baer, Stephan Hutter, Natalie Wossidlo, Gregor Hoermann

Leukemia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel genomic analysis from paired bone marrow and peripheral blood samples of 200 cytopenic patients.
Sandra Huber, Natalie Wossidlo, Torsten Haferlach, Stephan Hutter, Wencke Walter

Leukemia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interface-guided phenotyping of coding variants in the transcription factor RUNX1.
Kivilcim Ozturk, Rebecca Panwala, Jeanna Sheen, Kyle Ford, Nathan Jayne, Stephan Hutter

Cell Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genes.
Xueqi Cao, Sandra Huber, Ata Jadid Ahari, Franziska R Traube, Marc Seifert, Stephan Hutter

Genome Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in BCP-ALL of all age classes.
Heiko Müller, Frank Dicker, Constance Bär, Wencke Walter, Stephan Hutter

Hemasphere· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.
Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, Edward Ayoub, Marietta Truger, Stephan Hutter

Blood· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy.
Daria Frank, Pradeep Kumar Patnana, Jan Vorwerk, Lianghao Mao, Lavanya Mokada Gopal, Stephan Hutter

Blood· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
Anna Maierhofer, Nikita Mehta, Ryan A Chisholm, Stephan Hutter, Constance Baer

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC.
Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Irene Fuhrmann

Leukemia· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay of TP53 allelic state, blast count, and complex karyotype on survival of patients with AML and MDS.
Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interface-guided phenotyping of coding variants in the transcription factor RUNX1 with SEUSS.
Kivilcim Ozturk, Rebecca Panwala, Jeanna Sheen, Kyle Ford, Nathan Payne, Stephan Hutter

bioRxiv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific subtype distribution with impact on prognosis of TP53 single-hit and double-hit events in AML and MDS.
Anna Stengel, Torsten Haferlach, Constance Baer, Stephan Hutter, Manja Meggendorfer

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AML classification in the year 2023: How to avoid a Babylonian confusion of languages.
Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Manja Meggendorfer

Leukemia· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk prediction in MDS: independent validation of the IPSS-M-ready for routine?
Constance Baer, Sandra Huber, Stephan Hutter, Manja Meggendorfer, Niroshan Nadarajah

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDS subclassification-do we still have to count blasts?
Sandra Huber, Torsten Haferlach, Heiko Müller, Manja Meggendorfer, Stephan Hutter

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in spliceosome genes in myelodysplastic neoplasms and their association to ring sideroblasts.
Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann

Leukemia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase.
Sandra Huber, Torsten Haferlach, Manja Meggendorfer, Stephan Hutter, Gregor Hoermann

Leukemia· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis